本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Anaptysbio Inc

26.17
+0.25000.96%
盤後26.170.00000.00%16:04 EDT
成交量:49.55萬
成交額:1,316.43萬
市值:7.69億
市盈率:-5.46
高:27.34
開:26.26
低:25.74
收:25.92
資料載入中...
2021/02/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/19

重要事件披露

8-K - Current report
2021/01/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2020/11/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/17

重要事件披露

8-K - Current report
2020/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/10/26

重要事件披露

8-K - Current report
2020/10/13

重要事件披露

8-K - Current report
2020/08/20

重要事件披露

8-K - Current report